Search results
The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in...
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat...
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. [2]
5 dni temu · The latest Hemispherx Biopharma stock prices, stock quotes, news, and AIM history to help you invest and trade smarter.
30 wrz 2024 · Hemispherx BioPharma, Inc (ZB_15437.NYSE): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Hemispherx BioPharma, Inc | Nyse: | Nyse
In a challenging market environment, Hemispherx Biopharma Inc , trading under the ticker AIM, has seen its stock price touch a 52-week low, reaching a sobering $0.25. This latest...
It is an immunomodulatory double-stranded RNA drug similar to the prototypical RNA poly I:C. It was first synthesized in the 1970s and is manufactured by AIM ImmunoTech (formerly known as Hemispherx Biopharma). [2]
